The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain

Molecular Brain Research

Volumn 86, Issue 1-2, 2001, Pages 115-124

  Lee, Michael J ^a   Breese, Charles R ^c   Strook, MaryAnn L ^b   Leonard, Sherry ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Dopamine receptor; Haloperidol; Nicotine; Nicotinic receptor; Schizophrenia; Smoking

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE; NICOTINIC RECEPTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SCHIZOPHRENIA; SMOKING; THALAMUS;

ACONITINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN CHEMISTRY; DOPAMINE ANTAGONISTS; HALOPERIDOL; INSECTICIDES; MALE; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SMOKING; SPIPERONE; TRITIUM;

EID: 0035977703     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00274-6     Document Type: Article

References (51)

1. Schizophrenia, sensory gating, and nicotinic receptors
2. Drugs and the treatment of psychiatric disorders
3. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain
4. 3H]nicotine binding sites in human brain
5. Abnormal regulation of the high affinity nicotinic receptors in subjects with schizophrenia
6. 3H]nicotine binding in human postmortem brain
7. 3H]methyllycaconitine: A new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors
8. Schizophrenia and smoking: An epidemiological survey in a state hospital
9. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
10. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine
11. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration
12. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment
13. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells
14. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
15. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
16. Pharmacokinetics of haloperidol
17. Human neuronal nicotinic receptors
18. Purification and characterization of an alpha-bungarotoxin receptor that forms a functional nicotinic channel
19. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain
20. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: Homogenate binding and autoradiographic studies
21. NIMH Genetics Initiative Millenium Schizophrenia Consortium: Linkage analysis of African-American pedigrees
22. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors
23. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion
24. The role of nicotine and nicotinic receptors in psychopathology
25. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative
26. Structure and function of neuronal nicotinic acetylcholine receptors
27. Cholinergic gating of response to auditory stimuli in rat hippocampus
28. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
29. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
30. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
31. 14C]-haloperidol in rats
32. Pharmacokinetics of haloperidol decanoate in rats
33. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers
34. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover
35. 3H]epibatidine labels nicotinic receptors in rat brain: An autoradiographic study
36. Nicotine activates and desensitizes midbrain dopamine neurons
37. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density
38. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission
39. Nicotinic receptors in the development and modulation of CNS synapses
40. Cellular localization of α-bungarotoxin binding and α7 mRNA in the hippocampus related to auditory gating in the awake-behaving rat
41. 3H]nicotine eliminates low affinity binding
42. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors
43. Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific
44. Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo
45. Behavioural and biochemical adaptations to nicotine in rats: Influence of MK801, an NMDA receptor antagonist
46. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains
47. Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells
48. Methyllycaconitine: A selective probe for neuronal alpha-bungarotoxin binding sites
49. The dopamine hypothesis of schizophrenia: Current status, future prospects
50. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: Pharmacology of ligand binding and function
51. 3H]-spiperone in striatum